Pharmacogenomics and Pharmacoproteomics Studies ofPhosphodiesterase-5 (PDE5) Inhibitors and Paclitaxel Albumin-StabilizedNanoparticles as Sandwiched Anti-Cancer Nano Drugs between TwoDNA/RNA Molecules of Human Cancer Cells

@article{Heidari2016PharmacogenomicsAP,
  title={Pharmacogenomics and Pharmacoproteomics Studies ofPhosphodiesterase-5 (PDE5) Inhibitors and Paclitaxel Albumin-StabilizedNanoparticles as Sandwiched Anti-Cancer Nano Drugs between TwoDNA/RNA Molecules of Human Cancer Cells},
  author={Alireza Heidari},
  journal={Journal of Pharmacogenomics and Pharmacoproteomics},
  year={2016},
  volume={7}
}
  • A. Heidari
  • Published 2016
  • Biology, Chemistry, Medicine
  • Journal of Pharmacogenomics and Pharmacoproteomics
One of the most important goals in the medicine, pharmacology, pharmaceutical, physiological, clinical, biological, medical and medicinal sciences, biochemistry, pharmacogenomics and pharmacoproteomics of anti-cancer Nano drugs such as phosphodiesterase-5 (PDE5) inhibitors and paclitaxel albuminstabilized nanoparticles is the treatment. The present methods and techniques of Nano-structuring anti-cancer Nano drugs, especially phosphodiesterase-5 (PDE5) inhibitors and paclitaxel albuminstabilized… 
View via Publisher
99 Citations
Background Citations
54
Methods Citations
10
Results Citations
1

Figures from this paper

99 Citations

Nanomedicine-Based Combination Anti-Cancer Therapy between Nucleic Acids and Anti-Cancer Nano Drugs in Covalent Nano Drugs Delivery Systems for Selective Imaging and Treatmentof Human Brain Tumors Using Hyaluronic Acid, Alguronic Acid and Sodium Hyaluronate as Anti-Cancer Nano Drugs and Nucleic Acid
TLDR
The enzymatic copolymerization of aniline and hyaluronic acid, alguronic acid and sodium hyaluronate with Horseradish Peroxidase (HRP) in the presence of Sulfonated Polystyrene (SPS) as a template is reported.
Modern Approaches in Designing Ferritin, Ferritin Light Chain, Transferrin, Beta–2 Transferrin and Bacterioferritin–Based Anti–Cancer Nano Drugs Encapsulating Nanosphere as DNA–Binding Proteins from Starved Cells (DPS)
TLDR
This special form of non–classical energy input by synchrotron radiation still represents a fringe area of bio-catalysis, alternative reaction and chemical process engineering.
Pharmacogenomics and its Implementations
TLDR
Later on, pharmacogenomics will permit the advancement of custom-made medications to treat an extensive variety of wellbeing issues, including cardiovascular illness, Alzheimer infection, growth, HIV/AIDS, and asthma.
Transport Therapeutic Active Targeting of Human Brain Tumors Enable Anti Cancer Nanodrugs Delivery across the Blood Brain Barrier (BBB) to Treat Brain Diseases Using Nanoparticles and Nanocarriers under Synchrotron Radiation
TLDR
The transport therapeutic active targeting of human brain tumors enable anti–cancer nanodrugs delivery across the Blood–Brain Barrier to treat brain diseases using nanoparticles and nanocarriers under synchrotron radiation is proposed.
Palauamine and Olympiadane Nano Molecules Incorporation into the Nano Polymeric Matrix (NPM) by Immersion of the Nano Polymeric Modified Electrode (NPME) as Molecular Enzymes and Drug Targets for Human Cancer Cells, Tissues and Tumors Treatment under Synchrotron and Synchrocyclotron Radiations
In the current editorial, we study Palau’amine and Olympiadane Nano molecules (Figures 1 & 2) incorporation into the Nano Polymeric Matrix (NPM) by immersion of the Nano Polymeric Modified…
Uranocene (U(C8H8)2) and Bis(Cyclooctatetraene)Iron (Fe(C8H8)2 or Fe(COT)2)–Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI) Nano Molecules
In the current editorial, we study analogous Nano compounds of the form M(C8H8)2 exist for M = (Nd, Tb, Pu, Pa, Np, Th, and Yb)– Enhanced Precatalyst Preparation Stabilization and Initiation (EPPSI)…
Research and Reviews: Journal of Pharmaceutics and Nanotechnology Targeted Nanoparticles for Anti-Cancer Drug Delivery: A Review
TLDR
In this review report, the current status of nanoparticles developed as targeting delivery systems for anticancer drugs are discussed.
Design of Targeted Metal Chelation Therapeutics Nanocapsules as Colloidal Carriers and Blood-Brain Barrier (BBB) Translocation to Targeted Deliver Anti-Cancer Nano Drugs into the Human Brain to Treat Alzheimer's Disease under Synchrotron Radiation
TLDR
In this short communication, paclitaxel, camptothecin, doxorubicin, cisplatin and curcumin are most used anti–cancer nano drugs, which are tested for nano-medicinal and pharmaceutical applications.
A Novel Approach to Reduce Toxicities and to Improve Bioavailabilities of DNA/RNA of Human Cancer Cells–Containing Cocaine (Coke), Lysergide (Lysergic Acid Diethyl Amide or LSD), 9–Tetrahydrocannabin
TLDR
A Novel Approach to reduce Toxicities and to improve Bioavailabilities of DNA/RNA of Human Cancer Cells by Coassembly of Dual Anti–Cancer Nano Drugs to Inhibit DNA/ RNA of Human cancer Cells Drug Resistance.
Nanocarrier Mediated Drug Delivery
TLDR
Nanomedicine aims in delivering a set of clinical devices, research tools ranging from the applications of nanomaterials in medicine to Nanoelectronics and their application.
...
...

References

SHOWING 1-10 OF 39 REFERENCES
Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells.
Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells.
In vitro mechanistic and in vivo anti-tumor studies of Glycosmis pentaphylla (Retz.) DC against breast cancer.
Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs.
In vivo pharmacokinetics, biodistribution and the anti-tumor effect of cyclic RGD-modified doxorubicin-loaded polymers in tumor-bearing mice.
Mannosylated protamine as a novel DNA vaccine carrier for effective induction of anti-tumor immune responses.
Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer.
Pioglitazone, an anti-diabetic drug requires sustained MAPK activation for its anti-tumor activity in MCF7 breast cancer cells, independent of PPAR-γ pathway.
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2(+) Breast Cancer.
Anti-tumor effect via passive anti-angiogenesis of PEGylated liposomes encapsulating doxorubicin in drug resistant tumors.
...
...